News | April 11, 2026
Zydus improves ESG rating to 68, up from 66 last year
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The reports will now be shared with relevant ministries and departments as a guidance framework
New digital health companion uses friendly, jargon-free communication to help users better understand reports
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
20 among them to receive $20,000 grants
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Subscribe To Our Newsletter & Stay Updated
